Overview

• Mexico’s Secretaría de Salud reports 3.4 million BCG doses are under Cofepris review and expected to be released within about four weeks.
• The bottleneck arose after the main supplier moved its production plant in India, requiring a new sanitary registration.
• Available doses are sufficient for two years of routine infant vaccinations and will be offered free at public clinics and hospitals.
• Health authorities emphasize that children face no immediate risk because the BCG vaccine can be administered from birth up to four years old.
• The domestic shortage mirrors a global disruption that has also affected Australia, China and other countries.